Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Doug Soon who wrote (2899)	5/26/1998 1:06:00 PM
From: Brander	Read Replies (1) \| Respond to of 9523

Doug, concerning "I'm inclined to think that the story as we know it lacks a few important details." I certainly agree. The 6 deaths by themselves mean nothing. As I said before, either PFE does not know about the other 14 plus deaths that would be expected to occur under normal circumstances, or Viagra lowers the death rate. I think the former is probably true. PFE is required to report any deaths that occur while a person is taking Viagra that they know about. Under normal circumstances you would expect many more than 6. This reporting, by itself, in no way suggests a causal relationship. If the FDA or PFE thought at this time there was a likely causal relationship (outside the contraindication of nitrates), sales of Viagra would have been halted in the U.S. by now.

To: Doug Soon who wrote (2899)	5/26/1998 2:04:00 PM
From: zurdo	Read Replies (1) \| Respond to of 9523

A reuters report on 5/22/98 quoted the most recent statistics on deaths among men from the National Center for Health Statistics. It stated that 335 deaths from all causes could be expected in any given week among one million men aged between 45 and 74. It added that more than 500,000 men in that age group died in 1996 from all causes.